U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570823) titled 'A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma' on April 29.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of SCTB35 in Combination With Gemcitabine and Oxaliplatin vs Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
DLBCL - Diffuse Large B Cell Lymphoma
Intervention:
DRUG: SCTB35 injection
SCTB35 will be subcutaneously administ...